EUVIMEDEUVIMED entdecken
Crossref

X‐ray‐Activated Asymmetric Cobalt Single‐Atom Nanozyme Potentiates Catalytic Immunotherapy via Enhanced Peroxidase‐Like Activity

Bo Chen iD, Xuelin Tao, Yu Wang iD, Xiaoxiao Wang iD, Yongzhong Wu, Wanyi Chen iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Bo Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chongqing University Cancer Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Cobalt, Immunotherapy, Peroxidase. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Chongqing University Cancer Hospital, Chongqing Postdoctoral Special Funding, Basic Research Program of Guizhou Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single‐atom nanozymes (SAzymes) have emerged as promising platforms for catalytic therapy owing to their atomic precision and tunable electronic structures. Here, we report an asymmetrically coordinated cobalt SAzyme featuring Co‐N 3 C active sites anchored within a hafnium‐based metal–organic framework (Hf‐MOF). The engineered HfCoNC nanozyme exhibits significantly enhanced peroxidase‐like activity and enables efficient X‐ray–activated catalytic immunotherapy. The asymmetric Co‐N 3 C coordination optimizes substrate adsorption and lowers the reaction energy barrier, thereby accelerating the catalytic reaction. In the tumor microenvironment, HfCoNC efficiently converts endogenous H 2 O 2 into highly cytotoxic hydroxyl radicals (•OH), while low‐dose X‐ray irradiation further amplifies reactive oxygen species (ROS) production. The resulting oxidative stress induces extensive DNA damage and activates the cGAS‐STING signaling pathway. Moreover, the release of Co 2+ ions, together with the co‐delivered STING agonist, further potentiates systemic antitumor immunity, effectively suppressing tumor growth and metastasis. This work provides a promising strategy for developing SAzyme‐based platforms for synergistic catalytic radioimmunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CobaltImmunotherapyPeroxidaseAnimalsCatalysisMiceHumansX-RaysCell Line, TumorTumor MicroenvironmentcGAS-STING Signaling PathwayReactive Oxygen SpeciesHydrogen PeroxideMetal-Organic Frameworks

Stichwörter der Autor:innen

asymmetric coordinationcGAS‐STINGcatalytic immunotherapyperoxidase‐like activitysingle‐atom nanozyme

Substanzen

CobaltPeroxidaseReactive Oxygen SpeciesHydrogen PeroxideMetal-Organic Frameworks

Autor:innen und Institutionen

  • Department of Pharmacy, Chongqing University Cancer Hospital, Chongqing, China.
  • Scientific Research Center, The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University), Zunyi, China.
  • Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China.

ORCID-Profile: Bo Chen, Yu Wang, Xiaoxiao Wang, Wanyi Chen

Förderung

  • Chongqing University Cancer Hospital
  • Chongqing Postdoctoral Special Funding
  • Basic Research Program of Guizhou Provincial Department of Science and Technology
  • Startup research funds from The First People's Hospital of Zunyi (The Third Affiliated Hospital of Zunyi Medical University).

Zitieren

APA

Chen, B., Tao, X., Wang, Y., Wang, X., Wu, Y., & Chen, W. (2026). X‐ray‐Activated Asymmetric Cobalt Single‐Atom Nanozyme Potentiates Catalytic Immunotherapy via Enhanced Peroxidase‐Like Activity. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71740

Vancouver

Chen B, Tao X, Wang Y, Wang X, Wu Y, Chen W. X‐ray‐Activated Asymmetric Cobalt Single‐Atom Nanozyme Potentiates Catalytic Immunotherapy via Enhanced Peroxidase‐Like Activity. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71740

BibTeX
@article{Chen2026,
  author = {Chen, Bo and Tao, Xuelin and Wang, Yu and Wang, Xiaoxiao and Wu, Yongzhong and Chen, Wanyi},
  title = {X‐ray‐Activated Asymmetric Cobalt Single‐Atom Nanozyme Potentiates Catalytic Immunotherapy via Enhanced Peroxidase‐Like Activity},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71740}
}
Kostenlos starten →